Identification Generic Name (2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide DrugBank Accession Number DB07861 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide (DB07861) ×  Close Weight Average: 420.481  Monoisotopic: 420.114377828  Chemical Formula C 23 H 20 N 2 O 4 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Not Available Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 2-naphthalene sulfonic acids and derivatives. These are organic aromatic compounds that contain a naphthalene moiety that carries a sulfonic acid group (or a derivative thereof) at the 2-position. Naphthalene is a bicyclic compound that is made up of two fused benzene ring. Kingdom Organic compounds Super Class Benzenoids Class Naphthalenes Sub Class Naphthalene sulfonic acids and derivatives Direct Parent 2-naphthalene sulfonic acids and derivatives Alternative Parents 2-naphthalene sulfonamides  /  Alpha amino acids and derivatives  /  Organosulfonamides  /  Aminosulfonyl compounds  /  Hydroxamic acids  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds Substituents 2-naphthalene sulfonamide  /  2-naphthalene sulfonic acid or derivatives  /  Alpha-amino acid or derivatives  /  Aminosulfonyl compound  /  Aromatic homopolycyclic compound  /  Carbonyl group  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  Hydroxamic acid  /  N-substituted-alpha-amino acid Molecular Framework Aromatic homopolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key MMOUXLMPQFMDRD-JOCHJYFZSA-N InChI InChI=1S/C23H20N2O4S/c26-23(24-27)22(14-16-9-10-17-5-1-3-7-19(17)13-16)25-30(28,29)21-12-11-18-6-2-4-8-20(18)15-21/h1-13,15,22,25,27H,14H2,(H,24,26)/t22-/m1/s1 IUPAC Name (2R)-N-hydroxy-3-(naphthalen-2-yl)-2-(naphthalene-2-sulfonamido)propanamide SMILES [H][C@](CC1=CC2=C(C=CC=C2)C=C1)(NS(=O)(=O)C1=CC2=C(C=CC=C2)C=C1)C(=O)NO References General References Not Available External Links PubChem Compound 9823454 PubChem Substance 99444332 ChemSpider 7999201 ChEMBL CHEMBL261713 ZINC ZINC000000594749 PDBe Ligand GVR PDB Entries 2ves  /  4isa Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.000431 mg/mL ALOGPS logP 3.14 ALOGPS logP 3.67 Chemaxon logS -6 ALOGPS pKa (Strongest Acidic) 8.69 Chemaxon pKa (Strongest Basic) -5.5 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 95.5 Å 2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 114.8 m 3 ·mol -1 Chemaxon Polarizability 43.4 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.8505 Blood Brain Barrier + 0.6629 Caco-2 permeable - 0.6419 P-glycoprotein substrate Non-substrate 0.5549 P-glycoprotein inhibitor I Non-inhibitor 0.8916 P-glycoprotein inhibitor II Non-inhibitor 0.8709 Renal organic cation transporter Non-inhibitor 0.9359 CYP450 2C9 substrate Non-substrate 0.5908 CYP450 2D6 substrate Non-substrate 0.826 CYP450 3A4 substrate Non-substrate 0.6417 CYP450 1A2 substrate Non-inhibitor 0.7707 CYP450 2C9 inhibitor Non-inhibitor 0.711 CYP450 2D6 inhibitor Non-inhibitor 0.8779 CYP450 2C19 inhibitor Non-inhibitor 0.6661 CYP450 3A4 inhibitor Non-inhibitor 0.8251 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.7963 Ames test Non AMES toxic 0.6056 Carcinogenicity Non-carcinogens 0.7352 Biodegradation Not ready biodegradable 0.9965 Rat acute toxicity 2.3532 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9931 hERG inhibition (predictor II) Non-inhibitor 0.8742    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Kind Protein Organism Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228) Pharmacological action Unknown General Function Udp-3-o-[3-hydroxymyristoyl] n-acetylglucosamine deacetylase activity Specific Function Involved in the biosynthesis of lipid A, a phosphorylated glycolipid that anchors the lipopolysaccharide to the outer membrane of the cell. Gene Name lpxC Uniprot ID P47205 Uniprot Name UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Molecular Weight 33434.81 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 